Quick Answer
Fortress Biotech, Inc. reported Total Assets of $185.55 million for fiscal year 2025.
Fortress Biotech, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $185.55M | +28.7% |
| 2024 | $144.22M | -13.9% |
| 2023 | $167.53M | -43.1% |
| 2022 | $294.30M | -25.8% |
| 2021 | $396.50M | +18.9% |
| 2020 | $333.41M | +47.3% |
| 2019 | $226.42M | +60.6% |
| 2018 | $140.99M | -42.7% |
| 2017 | $245.95M | +44.1% |
| 2016 | $170.73M | +43.9% |
| 2015 | $118.61M | +32.8% |
| 2014 | $89.33M | -11.2% |
| 2013 | $100.58M | +145.4% |
| 2012 | $40.99M | +75.4% |
| 2011 | $23.38M | +56.5% |
| 2010 | $14.94M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $181.41M | +42.7% | +13.5% |
| June 30, 2025 | $159.90M | +9.8% | -10.2% |
| March 31, 2025 | $178.07M | +8.2% | +23.5% |
| December 31, 2024 | $144.22M | -13.9% | +13.5% |
| September 30, 2024 | $127.08M | -15.6% | -12.8% |
| June 30, 2024 | $145.69M | -19.4% | -11.5% |
| March 31, 2024 | $164.65M | -37.5% | -1.7% |
| December 31, 2023 | $167.53M | -43.1% | +11.3% |
- Fortress Biotech, Inc. showed an increase of +28.7% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Fortress Biotech, Inc.’s total assets has grown by 1142.0% (from $14.94 million to $185.55 million).
- The most recent figure is from Fortress Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: